Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents
Authors
Keywords
-
Journal
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 90, Issue 1, Pages 81-90
Publisher
Wiley
Online
2015-08-19
DOI
10.1002/cyto.b.21279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation
- (2015) A Brioli et al. BONE MARROW TRANSPLANTATION
- Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation
- (2014) Shuji Ozaki et al. ACTA HAEMATOLOGICA
- Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
- (2014) J. San-Miguel et al. BLOOD
- Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study
- (2014) S. Bringhen et al. BLOOD
- Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy
- (2014) Stéphanie Mathis et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Monoclonal antibodies currently in Phase II and III trials for multiple myeloma
- (2014) Francesca Donato et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
- (2014) M. Engelhardt et al. HAEMATOLOGICA
- Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
- (2014) Sufia Butt Hassan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma
- (2014) Jonathan J Douds et al. JOURNAL OF CLINICAL PATHOLOGY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
- (2014) M A Dimopoulos et al. LEUKEMIA
- European Perspective on Multiple Myeloma Treatment Strategies in 2014
- (2014) H. Ludwig et al. ONCOLOGIST
- Fine Specificity and Molecular Competition in SLAM Family Receptor Signalling
- (2014) Timothy J. Wilson et al. PLoS One
- Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma
- (2014) R Silvennoinen et al. Blood Cancer Journal
- What We Mean When We Talk About MRD in Myeloma. A Review of Current Methods. Part 1 of a Two-Part Series
- (2014) Scott Ely et al. Current Hematologic Malignancy Reports
- CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
- (2013) André Veillette et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study
- (2013) Wenli Zheng et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry
- (2013) Alex F. Sandes et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- New developments in the management and treatment of newly diagnosed and relapsed/refractory multiple myeloma patients
- (2013) Niels WCJ van de Donk et al. EXPERT OPINION ON PHARMACOTHERAPY
- Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance
- (2013) Laurence Menard et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- CD200 expression in patients with Multiple Myeloma: Another piece of the puzzle
- (2013) Concetta Conticello et al. LEUKEMIA RESEARCH
- Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
- (2013) Prashant R. Tembhare et al. LEUKEMIA RESEARCH
- Immunophenotypic Stability of CD200 Expression in Plasma Cell Myeloma
- (2012) Horatiu Olteanu et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Development of novel CXCR4-based therapeutics
- (2012) Amnon Peled et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
- (2011) Daisy Alapat et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
- (2011) Bruno Paiva et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders
- (2010) Karthick R. M. Raja et al. BRITISH JOURNAL OF HAEMATOLOGY
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
- (2010) M. Hussein et al. HAEMATOLOGICA
- Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation
- (2010) Beatriz Rodríguez-Bayona et al. IMMUNOLOGY LETTERS
- Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: From pro-B to plasma cells
- (2010) Jose De Salort et al. IMMUNOLOGY LETTERS
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion
- (2009) F. C. Rau et al. JOURNAL OF IMMUNOLOGY
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
- (2008) Gema Mateo et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer stem cells, CD200 and immunoevasion
- (2008) Brian T. Kawasaki et al. TRENDS IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started